A detailed history of Valence8 Us LP transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Valence8 Us LP holds 20,700 shares of GOSS stock, worth $15,318. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,700
Holding current value
$15,318
% of portfolio
0.01%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form

Others Institutions Holding GOSS

About Gossamer Bio, Inc.


  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $69.5M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Valence8 Us LP Portfolio

Follow Valence8 Us LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valence8 Us LP, based on Form 13F filings with the SEC.

News

Stay updated on Valence8 Us LP with notifications on news.